Company profile: Somatex
1.1 - Company Overview
Company description
- Provider of medical devices, located in Berlin.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Somatex
Pheon Therapeutics
HQ: United Kingdom
Website
- Description: Provider of antibody-drug conjugate (ADC) programs for difficult-to-treat cancers. Offerings include PHN-010, an ADC targeting a transmembrane protein over-expressed in multiple solid tumors with low expression in healthy tissues; development of first-in-class solid tumor programs with in vivo proof of concept; and proprietary payloads to overcome resistance, featuring novel modes of action and tunable potency.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pheon Therapeutics company profile →
Kuur Therapeutics
HQ: United Kingdom
Website
- Description: Provider of off-the-shelf engineered CAR-NKT cell therapies, combining the natural biology of natural killer T cells with innovative CAR constructs for cancer treatment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kuur Therapeutics company profile →
Eleison Pharmaceuticals
HQ: United States
Website
- Description: Provider of clinical-stage oncology drug candidates for orphan cancers through acquisition, development, and commercialization, including Glufosfamide (glucose-linked ifosforamide mustard targeting cancer cells to reduce normal-cell toxicity), Inhaled Lipid-Complexed Cisplatin for lung diseases (prolonged effect, enhanced uptake, reduced systemic toxicity), and Dibromodulcitol requiring further safety-equivalence studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eleison Pharmaceuticals company profile →
Ambit Biosciences
HQ: United States
Website
- Description: Provider of small molecule kinase inhibitor discovery and development for cancer, autoimmune, and inflammatory diseases, including quizartinib (AC220), a potent, selective FLT3 inhibitor for AML, AC410 (JAK2 inhibitor), and AC708 (CSF1R inhibitor), supported by the KinomeScan platform for screening kinase inhibitors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ambit Biosciences company profile →
Onco-NX
HQ: United Kingdom
Website
- Description: Provider of drug discovery research dedicated to identifying new promising anticancer agents as a University of Salford spin-out company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Onco-NX company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Somatex
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Somatex
2.2 - Growth funds investing in similar companies to Somatex
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Somatex
4.2 - Public trading comparable groups for Somatex
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →